Proven Track Record of Most Accurate Analysis
Proven Track Record
of Most Accurate Analysis
This post was just published on ZYX Buy Change Alert. FB has moved up since the recommendation yesterday. This post does not apply to the medium-term trade. It applies only to the short-term trade. Consider moving the stop to break even for the short-term trade.
This post was just published on ZYX Short Change Alert. XLP represents consumer staples. The upside has been overdone. Consider initiating a 10% tranche in the zone of $39.76 to $40.55. No stop for the time being as the position is being accumulated. Target zone is $35 to $36.50. The plan is to add to the position if XLP moves higher and nothing fundamental changes.
As if Apple needed more trouble, here comes a double whammy. First, Apple CEO Tim Cook had to apologize to the Chinese consumers. Second, Apple got a downgrade from a big Wall Street supporter. A popular new segment on China Central Television highlighted how Apple discriminated against Chinese consumers with its warranties and after-sales service. The Chinese media called Apple ‘greedy and arrogant.’ Cook is trying to take the sting out, “We always pay tribute to China, Chinese consumer is always the most important thing in our minds.” It is an old saying, ‘You cannot fight city hall.’ Apple was facing the state
This post was just published on ZYX Buy Change Alert. This idea is only for aggressive investors, conservative investors may consider staying away from this trade. There is a trade here for both medium-term and very short-term investors. Medium-Term Trade FB came public at $38, fell to $17.55, ran up to $32.52 and now has fallen back to $25.72 as of this writing. On Thursday there is a Facebook event. The invitation says, “Our new home on Android.” Rumors abound about a Facebook phone using HTC hardware running a highly customized flavor of Android. It is worth keeping in mind
It is official: India is siding with poor cancer patients over profits for multinational drug giants. The Supreme Court of India has rejected a plea by Swiss pharma giant Novartis that ends the seven-year legal battle to restrict Indian companies from copying blood cancer drug Glivec. Novartis had filed a plea with the Supreme Court after the Intellectual Property Appellate Board had rejected a patent claim for Glivec. Glivec is marketed as Gleevec in the United States. In 2001, Time magazine called it the magic bullet for cancer patients. The drug was originally developed as Imatinib using rational drug design after Philadelphia chromosome mutation was discovered. In India, Glivec
(The Weekly Digest reproduces the morning capsules made available every morning before the market open in the Real Time Feeds to the paying subscribers.) STRICT CAPITAL CONTROL IN CYPRUS March 28, 2013 Cyprus has become the first eurozone country to put limits on daily withdrawals, cashing checks, amount of credit card transactions, and money transfers. People can withdraw a maximum of 300 euro each day. People cannot take more than 3000 euros out of the country, and overseas credit card transactions cannot exceed 5000 euros per month. Gold is falling and stocks are taking encouragement because there are no riots in the
This post was just published on ZYX Buy Change Alert. VHS is a hospital chain. Buy zone is $13.07 to $15.11. Consider not accumulating more than 35% in this range. Most of the accumulation should take place under $14.55 and preferably near the bottom of the zone. In other words be patient and accumulate slowly on down spikes. Target zone is $18 to $20. The plan is to accumulate more if the stock goes lower and there is no change in fundamentals. No stops since the position is in the process of being accumulated however for those who must use
This morning BlackBerry released much anticipated earnings. After reviewing the earnings report, my conclusion is that it does not reveal much for a long-term investor since the company is in transition. The headline numbers were better than expected with one million BlackBerry Z10 phones sold. Here are the reasons why celebration for BlackBerry is premature: The one million number about Z10 is devices shipped. It is misleading in that one million devices are now in the channel in the hands of carriers and distributors. It would be plain wrong to state or assume that one million Z10 have been bought by end users. BlackBerry user